Advanced technology: regulatory requirements during the development and marketing phase of nanotechnology medicines
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentations + Posters
- By: TERCAN, Tugba Nevriye (Hacettepe University, Health Science Instute, Ankara, Turkey)
- Co-author(s): Çapan, Yilmaz (Hacettepe University, Faculty of Pharmacy, Dept. of Pharmaceutical Technology, Ankara, Turkey)
Sam, Tom (Schering-Plough, Oss, Netherlands)
Ten years from now nanotechnology-based medicines are expected to be a large proportion of the new medicines to be approved for marketing authorization. After an extensive introduction into the scientific aspects of this new technology the thesis describes how the current EU Union), USA and Turkish legislation deals with nanotechnology products... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.